AstraZeneca in $560 m deal for respiratory firm
Jun 10, 2013 | Posted by: roboblogger | Full story: Seattle Times
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Since: Apr 13
This sounds promising.
|Review: Vencoa Inc (Jul '12)||28 min||wellsteve||57|
|CA Judge overturns California's ban on same-sex ma... (Aug '10)||5 hr||Appeals||200,336|
|CA CA Proposition 23 - Global Warming (Oct '10)||6 hr||roaster||7,846|
|CA California Proposition 19: the Marijuana Legali... (Oct '10)||8 hr||Remote||15,917|
|Get Paid for Posts? Social Networking's New Twist||Thu||N8 the Grrr8||1|
|La Victoria's Orange Sauce (Jan '06)||Jul 23||Orange Sauce||127|
|CA Jury reaches verdict in Oakland BART shooting t... (Jul '10)||Jul 22||Ronald||2,251|